214 related articles for article (PubMed ID: 34414506)
1. Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis.
Bakke I; Walaas GA; Bruland T; Røyset ES; van Beelen Granlund A; Escudero-Hernández C; Thorsvik S; Münch A; Sandvik AK; Østvik AE
J Gastroenterol; 2021 Oct; 56(10):914-927. PubMed ID: 34414506
[TBL] [Abstract][Full Text] [Related]
2. Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease.
Thorsvik S; Damås JK; Granlund AV; Flo TH; Bergh K; Østvik AE; Sandvik AK
J Gastroenterol Hepatol; 2017 Jan; 32(1):128-135. PubMed ID: 27640344
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
Magro F; Lopes S; Coelho R; Cotter J; Dias de Castro F; Tavares de Sousa H; Salgado M; Andrade P; Vieira AI; Figueiredo P; Caldeira P; Sousa A; Duarte MA; Ávila F; Silva J; Moleiro J; Mendes S; Giestas S; Ministro P; Sousa P; Gonçalves R; Gonçalves B; Oliveira A; Chagas C; Torres J; Dias CC; Lopes J; Borralho P; Afonso J; Geboes K; Carneiro F;
J Crohns Colitis; 2017 Apr; 11(4):435-444. PubMed ID: 27664275
[TBL] [Abstract][Full Text] [Related]
4. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L
Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846
[TBL] [Abstract][Full Text] [Related]
5. Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
Zollner A; Schmiderer A; Reider SJ; Oberhuber G; Pfister A; Texler B; Watschinger C; Koch R; Effenberger M; Raine T; Tilg H; Moschen AR
J Crohns Colitis; 2021 Jan; 15(1):43-54. PubMed ID: 32556317
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity.
Oikonomou KA; Kapsoritakis AN; Theodoridou C; Karangelis D; Germenis A; Stefanidis I; Potamianos SP
J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942
[TBL] [Abstract][Full Text] [Related]
7. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
Lettesjö H; Hansson T; Peterson C; Ung KA; Ringström G; Abrahamsson H; Simrén M
Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277
[TBL] [Abstract][Full Text] [Related]
8. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
9. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
de Bruyn M; Arijs I; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Vermeire S; Opdenakker G
J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381
[TBL] [Abstract][Full Text] [Related]
10. [Fecal neutrophil gelatinase-associated lipocalin is a surrogate marker of inflammation in inflammatory bowel disease].
Zinkevich OD; Mukhametova DD; Abdulganieva DI; Safina NA; Koporulina MO; Odintsova AKh
Eksp Klin Gastroenterol; 2014; (10):22-7. PubMed ID: 25911926
[TBL] [Abstract][Full Text] [Related]
11. Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity.
Yeşil A; Gönen C; Senateş E; Paker N; Gökden Y; Koçhan K; Erdem ED; Gündüz F
Dig Dis Sci; 2013 Sep; 58(9):2587-93. PubMed ID: 23633156
[TBL] [Abstract][Full Text] [Related]
12. Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn's disease.
Thorsvik S; Bakke I; van Beelen Granlund A; Røyset ES; Damås JK; Østvik AE; Sandvik AK
Cell Tissue Res; 2018 Nov; 374(2):339-348. PubMed ID: 29869714
[TBL] [Abstract][Full Text] [Related]
13. Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's disease.
Budzynska A; Gawron-Kiszka M; Nowakowska-Dulawa E; Spiewak J; Lesinska M; Kukla M; Waluga M; Hartleb M
J Physiol Pharmacol; 2017 Dec; 68(6):859-865. PubMed ID: 29550798
[TBL] [Abstract][Full Text] [Related]
14. Ulcer-associated cell lineage expresses genes involved in regeneration and is hallmarked by high neutrophil gelatinase-associated lipocalin (NGAL) levels.
Thorsvik S; van Beelen Granlund A; Svendsen TD; Bakke I; Røyset ES; Flo TH; Damås JK; Østvik AE; Bruland T; Sandvik AK
J Pathol; 2019 Jul; 248(3):316-325. PubMed ID: 30746716
[TBL] [Abstract][Full Text] [Related]
15. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
[TBL] [Abstract][Full Text] [Related]
16. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
[TBL] [Abstract][Full Text] [Related]
17. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
Østvik AE; Granlund AV; Torp SH; Flatberg A; Beisvåg V; Waldum HL; Flo TH; Espevik T; Damås JK; Sandvik AK
Clin Exp Immunol; 2013 Sep; 173(3):502-11. PubMed ID: 23668802
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.
Ariza X; Graupera I; Coll M; Solà E; Barreto R; García E; Moreira R; Elia C; Morales-Ruiz M; Llopis M; Huelin P; Solé C; Fabrellas N; Weiss E; Nevens F; Gerbes A; Trebicka J; Saliba F; Fondevila C; Hernández-Gea V; Fernández J; Bernardi M; Arroyo V; Jiménez W; Deulofeu C; Pavesi M; Angeli P; Jalan R; Moreau R; Sancho-Bru P; Ginès P;
J Hepatol; 2016 Jul; 65(1):57-65. PubMed ID: 26988732
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and inflammatory faecal markers in collagenous colitis.
Wildt S; Nordgaard-Lassen I; Bendtsen F; Rumessen JJ
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):567-74. PubMed ID: 17556903
[TBL] [Abstract][Full Text] [Related]
20. Fecal and serum granulocyte protein levels in inflammatory bowel disease and irritable bowel syndrome and their relation to disease activity.
Ekoff H; Rydell N; Hellström PM; Movérare R
Clin Transl Gastroenterol; 2024 Jun; ():. PubMed ID: 38920307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
